The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain.
The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications.
Patients with multiple episodes of severe gout attacks every year or with tophi on examination need to be put on uric acid lowering therapy. Using uric acid lowering agents helps reduce the frequency of gout attacks, and reduces tophi formation with reduced risk of joint destruction.
The effective management of gout involves a set of general principles regardless of the anti-inflammatory agent that is used. This includes early treatment, duration of therapy, gout flare prophylaxis, continuing urate-lowering therapy during attacks, tophaceous gout, comorbidities, and adjunctive measures.
Several different therapies, which include systemic and intraarticular glucocorticoids, colchicine, and nonsteroidal anti-inflammatory drugs are effective for the treatment of severe gout; however, there is no single best agent that works for all patients experiencing a severe flare of gout. The availability of a host of agents and treatment approaches likely to benefit gives the opportunity to choose which therapy is likely to work. The agent and therapy can be chosen depending on an assessment of specific symptoms and severity of the condition for a patient and the flare history, and which is most likely to provide benefit minimizing the risk of adverse therapeutic effects.
Global Gout Therapeutics Market: Overview
Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. But in the recent times, especially in the U.S., the prevalence of gout has increased to greater extents, which is a reflection of growing population with obesity, smoking habits, and increased intake of alcohol. Increased level of uric acid in the body and uncontrolled metabolic disorders are some of the common symptoms of gout.
There are a number of therapies available for the treatment of gout, which also helps in preventing future flares and reduce the risk of kidney stone. These therapies help in reducing the uric acid levels in the body as well as enhance kidney’s ability to discard uric acid via urine. Consequently, the demand in the global gout therapeutics market is expected to increment at a healthy CAGR during the forecast period of 2017 to 2025.
Global Gout Therapeutics Market: Key Trends
Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to patients on the basis of severity of the condition. Introduction of urate-lowering agents is one of the primary driver of the gout therapeutics market. First line therapies such as Febuxostat and Allopurinol are now replaced urate-lowering agents such as Lesinurad, which help in reducing pain as well as negotiate the risk of joint destruction. The growing popularity of OTC drugs such as Oral colchicine, corticosteroids, and NASAIDs, which are quite effective in moderate gout indications, are also favoring the global gout therapeutics market in the positive direction. Technological advancements in medical imaging is another factor augmenting the demand in the gout therapeutics market. On the other hand, low levels of physician and patient awareness, heavy dependency on generic drugs, and use of CAM for the treatment of gout are restraining factors over the global gout therapeutics market.
Global Gout Therapeutics Market: Market Potential
Focus on regenerative medicines, high growth potential of biologics, and preference of combination therapies such as are some of the trends that bode well for the future of gout therapeutics market. Biologics such as Canakinumab, Rilonacept, and Krystexxa have been proven to efficiently address gout-related conditions. Combination therapies such as allopurinol and benzbromarone are able to treat gout by reducing the renal dyfunction.
GET TABLE OF CONTENT OF THE REPORT
Global Gout Therapeutics Market: Regional Outlook
Currently, North America serves the maximum demand in the global gout therapeutics market, owing to the presence of several prominent players in the U.S., high cost of branded therapies in the U.S., and growing use of gout therapy. Throughout the forecast period, North America is expected to remain the most lucrative market, also gaining traction from impending launch of several urate-lowering agents. On the other hand, vastly populated Asia Pacific is another lucrative region for the vendors venturing in this market. This region not only has a large pool of patients, improving healthcare infrastructure in emerging economies such as India, Japan, and Malaysia as well as changing lifestyle with smoking- and alcohol-related diseases will further escalate the demand in the gout treatment market.
Global Gout Therapeutics Market: Competitive Landscape
Horizon Pharma, AstraZeneca, and Takeda Pharmaceuticals are identified as the most prominent companies in moderately consolidated market for gout therapeutics. These companies lead via research and development and have a profile of drugs with high efficacy.
Novartis, Eli Lilly, Alder Biopharmaceuticals, Can-Fite BioPharma, Celgene, Ablynx, Lexicon Pharmaceuticals, Merck, Boehringer Ingelheim, Celltrion, CymaBay Therapeutics, GlaxoSmithKline, ChemoCentryx, Gilead Sciences, Ironwood Pharmaceuticals, Incyte, KaloBios Pharmaceuticals, Morphotek, Sanofi, Santarus, and Selecta Biosciences are some of the other key companies in the global gout therapeutics market.
GET DISCOUNT ON THE LATEST REPORT
TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.
5-Point Growth Formula
The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.
The 5-point growth formula includes the following points:
- Current and Future Threats
- Accurate Trend Analysis
- Regional Assessment
- Industrial Analogy
- COVID-19 Impact
Current and Future Threats
Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.
Accurate Trend Analysis
Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.
Regional Assessment
Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.
Industrial Analogy
The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.
COVID-19 Impact
The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.
The reports offer answers to the top 7 questions that revolve around the growth of the market
- What are the diverse growth parameters influencing the market?
- Which regions will contribute largely to the growth of the market
- What are the recent innovations and technological advancements in the market?
- What are the emerging trends across the market?
- How has COVID-19 affected the market?
- What will be the post-pandemic scenario of the market?
- What are the major threats that will dent the growth prospects of the market?
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Contact:
Rohit Bhisey
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Visit Site: https://www.tmrresearch.com/